福斯科林逆转了GABAAR电流幅度在海马突触的O-GlcNAcylation依赖的下降,可能在GABAARs的神经类固醇部位ARs
Shekinah Phillips1,2, John C Chatham3, Lori L McMahon4,5
1Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.
Scientific reports
|July 29, 2024
概括
增加O-GlcNAcylation可以逆转GABAergic抑制抑郁症. 增强的O-GlcNAcylation揭示了海马细胞中GABAergic突触电流的神经类强化.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 生物化学 生物化学
背景情况:
- 翻译后的修改,包括酸化和O-GlcNAcylation,关键调节GABAergic传输.
- O-GlcNAcylation,即添加β-N-乙糖胺,影响GABA受体的功能.
- 之前的研究表明,急性O-GlcNAcylation可以降低GABAergic电流.
研究的目的:
- 研究O-GlcNAcylation和酸化在调节GABAergic抑制后突触电流 (IPSCs) 中的相互作用.
- 为了确定O-GlcNAcylation是否影响神经类固醇对GABAergic传播的影响.
主要方法:
- 在海马主要细胞中IPSCs的电生理记录.
- 对O-GlcNAcylation和血清酸化水平的药理学操纵.
- 评估福斯科林和神经类固醇 (THDOC,孕激素) 对IPSC振幅的影响.
主要成果:
- 虽然福斯科林单独没有改变基线IPSC振幅,但之前的O-GlcNAcylation增强揭示了福斯科林依赖的强化,逆转了O-GlcNAc诱导的抑郁症.
- 福斯科林的增强作用独立于腺酸环酶和蛋白质激酶A.
- 增加的O-GlcNAcylation还揭示了神经类固醇THDOC和孕激素在细胞子集中的增强作用.
结论:
- 增高的O-GlcNAcylation可以通过其他因素改变GABAergic传输的调节.
- 在高O-GlcNAcylation下,GABAA受体上的神经类固醇结合部位可能变得更容易获得,加强突触抑制.
相关概念视频
01:09GPCRs Regulate Adenylyl Cylase Activity
5.4K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.4K
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.2K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.2K
01:12GPCR Desensitization
5.9K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
5.9K
01:21G-Protein Gated Ion Channels
4.6K
GPCRs are primarily responsible for our sense of smell, taste, and vision. The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
Sensory...
4.6K
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.8K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.8K
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
363
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
363